Sulphamethoxazole combined with 2-4-diamino-pyrimidines in the treatment of gonorrhoea.
D000208:Acute Disease; D002353:Carrier State / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005493:Folic Acid Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011739:Pyrimethamine / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage* / Q000009:adverse effects; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000009:adverse effects; D014522:Urethral Diseases / Q000382:microbiology
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole; D011739:Pyrimethamine